West Pharma (WST) Tops Q2 EPS by 5c
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Price: $358.24 -1.16%
Revenue Growth %: +9.6%
Financial Fact:
Income before income taxes: 49.3M
Today's EPS Names:
UBAB, LOAN, FITB, More
Revenue Growth %: +9.6%
Financial Fact:
Income before income taxes: 49.3M
Today's EPS Names:
UBAB, LOAN, FITB, More
Join SI Premium – FREE
West Pharmaceutical Services, Inc. (NYSE: WST) reported Q2 EPS of $0.52, $0.05 better than the analyst estimate of $0.47. Revenue for the quarter came in at $368.9 million versus the consensus estimate of $368.6 million.
West Pharmaceutical Services, Inc. reaffirmed FY2014 guidance.
For earnings history and earnings-related data on West Pharmaceutical Services, Inc. (WST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The tech crown switches hands: Apple dethrones Nvidia as $4 trillion king
- Nolan’s ’The Odyssey’ eyes $200M global debut, benefiting IMAX and theater stocks
- Citizens Financial Group (CFG) PT Raised to $85 at DA Davidson
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
